Angiotensin II-induced superoxide anion generation in human vascular endothelial cells. Role of membrane-bound NADH-/NADPH-oxidases

Cardiovascular Research

Volumn 44, Issue 1, 1999, Pages 215-222

  Zhang, Hong ^a   Schmeißer, Alexander ^a   Garlichs, Christoph D ^a   Plötze, Katrin ^b   Damme, Uwe ^b   Mügge, Andreas ^c   Daniel, Werner G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b University Heart Center Dresden   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Angiotensin II; Endothelial cell; NADH NADPH oxidase; Superoxide anion

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; BENZYLSULFONYL FLUORIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; LISINOPRIL; LOSARTAN; NITRIC OXIDE; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERTENSION; NEUTROPHIL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; IMIDAZOLES; LISINOPRIL; LOSARTAN; NADH DEHYDROGENASE; NADPH OXIDASE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STIMULATION, CHEMICAL; SUPEROXIDES;

EID: 0033215046     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00183-2     Document Type: Article

References (36)

1. Dzau V.J. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic Res Cardiol. 88:(Suppl 1):1993;1-14.
2. Fyhrquist F., Metsarinne K., Tikkanen I. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens. 9:(Suppl 5):1995;S19-24.
3. Kobayashi M., Uesugi S. The role of hypertension as a risk factor of atherosclerosis. Rinsho Byori. 43:(2):1995;104-110.
4. Keidar S., Kaplan M., Hoffman A., Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis. 115:(2):1995;201-215.
5. Das U.N. Can free radicals induce coronary vasospasm and acute myocardial infarction? Med Hypotheses. 39:(1):1992;90-94.
6. Laragh J.H. Role of renin secretion and kidney function in hypertension and attendant heart attack and stroke. Clin Exp Hypertens A. 14:(1-2):1992;285-305.
7. Holtz J., Goetz R.M. Vascular renin-angiotensin system, endothelial function and atherosclerosis? Basic Res Cardiol. 89:(Suppl 1):1994;71-86.
8. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:(6):1994;1141-1148.
9. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 97:(8):1996;1916-1923.
10. Massaeli H., Pierce G.N. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc Res. 29:1995;597-603.
11. Morel D.W., DiCorleto P.E., Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:1984;357-364.
12. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
13. Mugge A., Brandes R.P., Boger R.H., et al. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 24:(6):1994;994-998.
14. Aviram M. Modified forms of low density lipoprotein and atherogenesis. Atherosclerosis. 98:1993;1-10.
15. Fukui T., Lassegue B., Kai H., Alexander R.W., Griendling K.K. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta. 1231:(3):1995;215-219.
16. Jones S.A., O'Donnell V.B., Wood J.D., et al. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 271:1996;H1626-34.
17. Kessels G.C.R., Krause K.H., Verhoeven J.A. Protein kinase C activity is not involved in fMLP-induced phospholipase D activation in human neutrophils, but essential for concomitant NADPH oxidase activation:studies with a staurosporine analogue with improved selectivity for protein kinase C. Biochem J. 292:1993;781-785.
18. Mukoyama M., Nakajima M., Horiuchi M., et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 268:1993;24539-24542.
19. deGasparo M., Whitebread S., Mele M., et al. Biochemical characterization of two angiotensin II receptor subtypes in the rat. J Cardiovasc Pharmacol. 16:(supple 4):1990;S31-5.
20. Stoll M., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 95:1995;651-657.
21. Stoll M., Meffert S., Stroth U., Unger T. Growth or antigrowth angiotensin and the endothelium. J Hypertens. 13:1995;1529-1534.
22. Olson S.C., Dowds T.A., Pino P.A., Barry M.T., BurkeWolin T. ANG II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. Am J Physiol. 273:(2 Pt 1):1997;L315-21.
23. Mohazzab K.M., Kaminski P.M., Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 266:1994;H2568-72.
24. RegitzZagrosek V., NeuB M., Holzmeister J., Warnecke C., Fleck E. Molecular biology of angiotensin receptor and their role in human cardiovascular disease. J Mol Med. 74:1996;233-251.
25. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 14:(6):1994;1007-1013.
26. Agwu D.E., McPhail L.C., Sozzani S., Bass D.A., McCall C.E. Phosphatidic acid as second messenger in human polymorphonuclear leukocytes. J Clin Invest. 88:1991;531-539.
27. Nick J.A., Avdi N.J., Young S.K., et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest. 99:(5):1997;975-986.
28. Steinbrecher U.P., Zhang H.F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 9:(2):1990;155-168.
29. Brandes R., Barton M., Phillipens K.M.H., Schwietzer G., Mugge A. Production of superoxide anions in intact coronary arteries by the endothelium: evidences from lucigenin-dependent chemiluminescence and histological techniques. J Physiol Lond. 500:1997;331-342.
30. Ushio Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. p22phox Is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 271:(38):1996;23317-23321.
31. Mugge A., Daniel W.G., Haverich A., Lichtlen P.R. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation. 83:(1):1991;70-78.
32. Jackson B., Mendelsohn F.A.O., Johnston C.I. Angiotensin-converting enzyme inhibition: prospects for the future. J Cardiovasc Pharmacol. 18:(suppl 7):1991;S4-8.
33. Lindpaintner K., Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res. 68:1991;905-921.
34. Alderman M.H., Madhavan S., Ooi W.L., et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. New Engl J Med. 324:1991;1098-1103.
35. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
36. Ball S.G. Cardioprotection and ACE inhibitors. Clin Physiol Biochem. 9:(3):1992;98-104.